ABO Blood Group Differentials on Survival in Hepatocellular Carcinoma Patients Treated with Chemoembolization

BACKGROUND: The association between ABO blood group and the prognosis of hepatocellular carcinoma (HCC) remains unclear. We investigated the impact of ABO blood groups as a prognostic factor in HCC patients treated with transarterial chemoembolization (TACE). MATERIALS AND METHODS: We revisited reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Bannangkoon, Kittipitch, Hongsaku, Keerati, Sripongpun, Pimsiri, Kaewdech, Apichat, Chamroonkul, Naichaya, Tubtawee, Teeravut, Piratvisuth, Teerha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068171/
https://www.ncbi.nlm.nih.gov/pubmed/34837928
http://dx.doi.org/10.31557/APJCP.2021.22.11.3685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068171/
https://www.ncbi.nlm.nih.gov/pubmed/34837928
http://dx.doi.org/10.31557/APJCP.2021.22.11.3685

Ejemplares similares